A heparin‐like anticoagulant in an 8‐month‐old boy with acute monoblastic leukemia
- 1 January 1984
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 16 (1) , 83-90
- https://doi.org/10.1002/ajh.2830160111
Abstract
An 8‐month‐old male with acute monoblastic leukemia died during induction chemotherapy of severe bleeding refractory to repeated infusions of platelets and clotting factors. A heparin effect was suggested by prothrombin time (PT) of 26 seconds, partial thromboplastin time (PTT) of 94 seconds, thrombin time 240 seconds, and reptilase time 18.4 seconds, with a fibrinogen of 88 mg/dl. Both plasma mixed with the patient's urine and the patient's plasma had their thrombin times corrected toward normal by both PF4 and protamine. Synergism of of the anticoagulant with antithrombin III was demonstrated not only by enhanced inhibition of thrombin but also by an increased rate of formation of thrombin‐antithrombin III complexes in the presence of the anticoagulant, which was eliminated by preincubation with heparinase. Since the anticoagulant activity was not found in the blasts themselves, it is presumed that the anticoagulant is heparin/heparan liberated from the endothelial lining by products of the cell destruction secondary to chemotherapy.Keywords
This publication has 23 references indexed in Scilit:
- An acquired coagulation inhibitor to factor IIBritish Journal of Haematology, 1982
- A novel semi-synthetic sulphated polysaccharide with potent antithrombin activityBritish Journal of Haematology, 1982
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.Journal of Clinical Investigation, 1980
- Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.Journal of Clinical Investigation, 1980
- Dysfibrinogenemia Associated with HepatomaNew England Journal of Medicine, 1978
- A HEPARIN ANALOGUE WITH SPECIFIC ACTION ON ANTITHROMBIN IIIThe Lancet, 1977
- The anticoagulant effect of heparan sulfate and dermatan sulfateThrombosis Research, 1976
- Enzymatic degradation of heparin-related mucopolysaccharides from the surface of endothelial cell culturesBiochimica et Biophysica Acta (BBA) - General Subjects, 1975
- Inhibition of the Thrombin‐Fibrinogen Reaction by Heparin and Purified CofactorScandinavian Journal of Haematology, 1968
- CIRCULATING ANTICOAGULANTSMedicine, 1961